UBI Pharma Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 291.778 million compared to TWD 225.932 million a year ago. Operating loss was TWD 30.201 million compared to TWD 89.004 million a year ago. Net loss was TWD 39.218 million compared to TWD 89.323 million a year ago. Basic loss per share was TWD 0.43 compared to TWD 1.1 a year ago.